SCPHARMACEUTICALS INC.

Profile

Company Names

SCPHARMACEUTICALS INC.

Addresses

131 HARTWELL AVENUE, SUITE 215, LEXINGTON, MA 02421

75 ARLINGTON STREET, SUITE 500, BOSTON, MA 02116

Phone Numbers

617-517-0730

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$63,615,804.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2016-12-22 
$46,962,788.00 
$46,962,788.00 
$0.00 
Equity 
3
2016-08-22 
$4,000,000.00 
$10,000,000.00 
$6,000,000.00 
Debt 
2
2016-01-21 
$3,600,000.00 
$7,500,000.00 
$3,900,000.00 
Debt 
1
2014-03-24 
$9,053,016.00 
$17,053,016.00 
$8,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
METTE 
 
AGGER 
DIRECTOR
THESAN PHARMACEUTICALS, INC.   |  SCPHARMACEUTICALS INC.
METTE 
KIRSTINE 
AGGER 
DIRECTOR
ALLOCURE INC   |  SCPHARMACEUTICALS INC.   |  IMARA INC.   |  TREVI THERAPEUTICS, INC.   |  CYDAN II, INC.   |  TIBURIO THERAPEUTICS INC.
ABRAHAM 
 
CEESAY 
EXECUTIVE OFFICER
SCPHARMACEUTICALS INC.
DOROTHY 
 
COLEMAN 
DIRECTOR
SCPHARMACEUTICALS INC.
ABHAY 
 
GANDHI 
DIRECTOR
SCPHARMACEUTICALS INC.
TROY 
 
IGNELZI 
EXECUTIVE OFFICER
JUVENTAS THERAPEUTICS INC   |  SCPHARMACEUTICALS INC.   |  VEDANTA BIOSCIENCES, INC.
JACK 
 
KHATTAR 
DIRECTOR
SCPHARMACEUTICALS INC.
PIETER 
 
MUNTENDAM 
EXECUTIVE OFFICER, DIRECTOR
BG MEDICINE, INC.   |  SCPHARMACEUTICALS INC.
KUSH 
 
PARMAR 
DIRECTOR
ARVINAS, INC.   |  SCPHARMACEUTICALS INC.   |  AUDENTES THERAPEUTICS, INC.   |  ARVINAS HOLDING COMPANY, LLC   |  HOMOLOGY MEDICINES, INC.   |  5AM VENTURES V, L.P.   |  CYCLOPORTERS, INC.   |  AKOUOS, INC.   |  ENTRADA THERAPEUTICS, INC.   |  ARVINAS, INC.   |  RALLYBIO HOLDINGS, LLC   |  VOR BIOPHARMA INC.   |  ENSOMA, INC.
LEONARD 
 
SCHAEFFER 
DIRECTOR
QUINTILES TRANSNATIONAL HOLDINGS INC.   |  SCPHARMACEUTICALS INC.
JONATHAN 
 
SILVERSTEIN 
DIRECTOR
CERAPEDICS INC   |  ENOBIA PHARMA CORP   |  DFINE INC   |  RELYPSA INC   |  ROKA BIOSCIENCE, INC.   |  ASCENDIS PHARMA A/S   |  AUDENTES THERAPEUTICS, INC.   |  ADICET BIO, INC.   |  RHYTHM PHARMACEUTICALS, INC.   |  SCPHARMACEUTICALS INC.   |  AVEDRO INC   |  NEUROPACE INC   |  SPRINGBOX LABS, INC.   |  ARCUTIS BIOTHERAPEUTICS, INC.   |  SURMOUNT BIO, INC.   |  VANQUA BIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-01-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-22 
2016-09-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2016-08-22 
2016-09-06
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-08-22 
2016-02-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2016-01-21 
2014-04-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-03-24 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#